Recently, we revealed the cytotoxic activity of a small molecular weight FOXO1 inhibitor AS1842856 against BCP-ALL in in vitro, ex vivo, and in vivo models [21]. The gene discussed is FOXO1; the disease is acute lymphoblastic leukemia.